New eye drops aim to halt Vision-Threatening keratoconus
NCT ID NCT07388069
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early study tests whether TN-001 eye drops are safe and can stop keratoconus, a disease that thins and bulges the cornea, from getting worse. About 20 adults with progressive keratoconus will use the drops twice daily for 3-6 weeks. Researchers will monitor for side effects and check if the treatment stabilizes the cornea.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for KERATOCONUS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Ophthalmic Trials Australia
Brisbane, Queensland, 4005, Australia
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a simple eye treatment stop the need for a corneal transplant?
- Eye insert could ease allergy symptoms for contact lens wearers
- Promising new eye treatment could halt vision loss from keratoconus
- Promising new eye treatment could halt vision loss from keratoconus
- New study tests Same-Day treatment for Cone-Shaped corneas
- Can a simple questionnaire on eye rubbing help fight a rare eye disease?